This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Most Interesting New ETFs: Sports Betting & Telemedicine
by Neena Mishra
We highlight the first sports betting ETF and a digital health ETF
iRhythm (IRTC) Looks Good: Stock Adds 9.6% in Session
by Zacks Equity Research
iRhythm (IRTC) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
IRHYTHM TECH (IRTC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 40.35% and 3.49%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: IRHYTHM TECH (IRTC) Q1 Earnings Expected to Decline
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
IRHYTHM TECH (IRTC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -25.00% and 0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -89.74% and 4.73%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sony (SNE) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Amid a challenging business environment, strategic partnerships and state-of-the-art product launches are likely to have benefited Sony's (SNE) fiscal second-quarter 2019 financial performance.
iRhythm Technologies Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
iRhythm Technologies has been struggling lately, but the selling pressure may be coming to an end soon.
IRHYTHM TECH (IRTC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -2.22% and 6.89%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 34.00% and 8.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -4.35% and 6.03%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Will IRHYTHM TECH (IRTC) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 2.27% and 7.61%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Cerner (CERN) Looks Good: Stock Adds 5.1% in Session
by Zacks Equity Research
Cerner (CERN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
IRHYTHM TECH (IRTC) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -21.43% and 9.10%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?